Current Insights in the Development of Efficacious Vaccines Against RSV

Jorge A. Soto; Laura M. Stephens; Kody A. Waldstein; Gisela Canedo-Marroquín; Steven M. Varga; Alexis M. Kalergis

doi:10.3389/fimmu.2020.01507

Current Insights in the Development of Efficacious Vaccines Against RSV

Jorge A. Soto, Laura M. Stephens, Kody A. Waldstein, Gisela Canedo-Marroquín, Steven M. Varga, Alexis M. Kalergis^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Original language	English
Article number	1507
Journal	Frontiers in Immunology
Volume	11
DOIs	https://doi.org/10.3389/fimmu.2020.01507
State	Published - 17 Jul 2020
Externally published	Yes

Bibliographical note

Funding Information:
This research was funded by FONDECYT 1190830, 3190590 and the Millennium Institute on Immunology and Immunotherapy P09/016-F. This work was supported by the Department of Microbiology and Immunology at the University of Iowa (to SV) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH, R01AI124093 to SV and T32AI007485 to LS).

Funding Information:
AK is a Helen C. Levitt visiting professor at the Department of Microbiology and Immunology of the University of Iowa. Funding. This research was funded by FONDECYT 1190830, 3190590 and the Millennium Institute on Immunology and Immunotherapy P09/016-F. This work was supported by the Department of Microbiology and Immunology at the University of Iowa (to SV) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH, R01AI124093 to SV and T32AI007485 to LS).

Keywords

Respiratory Syncytial Virus
T cells
antibodies
treatments
vaccines

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fimmu.2020.01507

Cite this

@article{0c666c2097484d359f9beff5e80092a0,

title = "Current Insights in the Development of Efficacious Vaccines Against RSV",

keywords = "Respiratory Syncytial Virus, T cells, antibodies, treatments, vaccines",

author = "Soto, {Jorge A.} and Stephens, {Laura M.} and Waldstein, {Kody A.} and Gisela Canedo-Marroqu{\'i}n and Varga, {Steven M.} and Kalergis, {Alexis M.}",

note = "Funding Information: This research was funded by FONDECYT 1190830, 3190590 and the Millennium Institute on Immunology and Immunotherapy P09/016-F. This work was supported by the Department of Microbiology and Immunology at the University of Iowa (to SV) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH, R01AI124093 to SV and T32AI007485 to LS). Funding Information: AK is a Helen C. Levitt visiting professor at the Department of Microbiology and Immunology of the University of Iowa. Funding. This research was funded by FONDECYT 1190830, 3190590 and the Millennium Institute on Immunology and Immunotherapy P09/016-F. This work was supported by the Department of Microbiology and Immunology at the University of Iowa (to SV) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH, R01AI124093 to SV and T32AI007485 to LS).",

year = "2020",

month = jul,

day = "17",

doi = "10.3389/fimmu.2020.01507",

language = "English",

volume = "11",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Current Insights in the Development of Efficacious Vaccines Against RSV

AU - Soto, Jorge A.

AU - Stephens, Laura M.

AU - Waldstein, Kody A.

AU - Canedo-Marroquín, Gisela

AU - Varga, Steven M.

AU - Kalergis, Alexis M.

N1 - Funding Information: This research was funded by FONDECYT 1190830, 3190590 and the Millennium Institute on Immunology and Immunotherapy P09/016-F. This work was supported by the Department of Microbiology and Immunology at the University of Iowa (to SV) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH, R01AI124093 to SV and T32AI007485 to LS). Funding Information: AK is a Helen C. Levitt visiting professor at the Department of Microbiology and Immunology of the University of Iowa. Funding. This research was funded by FONDECYT 1190830, 3190590 and the Millennium Institute on Immunology and Immunotherapy P09/016-F. This work was supported by the Department of Microbiology and Immunology at the University of Iowa (to SV) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH, R01AI124093 to SV and T32AI007485 to LS).

PY - 2020/7/17

Y1 - 2020/7/17

KW - Respiratory Syncytial Virus

KW - T cells

KW - antibodies

KW - treatments

KW - vaccines

UR - http://www.scopus.com/inward/record.url?scp=85088949452&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2020.01507

DO - 10.3389/fimmu.2020.01507

M3 - Article

C2 - 32765520

AN - SCOPUS:85088949452

SN - 1664-3224

VL - 11

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1507

ER -

Current Insights in the Development of Efficacious Vaccines Against RSV

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Cite this